Matches in Wikidata for { <http://www.wikidata.org/entity/Q99400845> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q99400845 description "article scientifique publié en 2020" @default.
- Q99400845 description "articolo scientifico (pubblicato il 2020)" @default.
- Q99400845 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q99400845 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q99400845 description "im Jahr 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q99400845 description "scientific article published on 01 January 2020" @default.
- Q99400845 description "wetenschappelijk artikel" @default.
- Q99400845 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q99400845 description "научна статия" @default.
- Q99400845 name "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 name "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 name "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 type Item @default.
- Q99400845 label "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 label "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 label "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 prefLabel "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 prefLabel "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 prefLabel "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 P1433 Q99400845-BFC8C9F7-9FFD-4C56-95FD-A66895E677C4 @default.
- Q99400845 P1476 Q99400845-77F27E9D-EBCF-4582-BE81-372EF6C53B0F @default.
- Q99400845 P2093 Q99400845-1A8D4E15-ABFE-4663-9C68-0A5180CFCAAD @default.
- Q99400845 P2093 Q99400845-1D2BABD7-857D-4602-95D6-2D87E5321866 @default.
- Q99400845 P2093 Q99400845-1FBCA80E-E7C3-4398-B307-92DB2934F43B @default.
- Q99400845 P2093 Q99400845-2384141D-BE98-456C-8AC9-FDCF5C986F48 @default.
- Q99400845 P2093 Q99400845-32AA542A-7B82-418E-AE5A-B1BA162584A3 @default.
- Q99400845 P2093 Q99400845-3DE3ADD0-BBFB-4535-A0E1-C5FC438F7F7D @default.
- Q99400845 P2093 Q99400845-690D2621-94B2-4CBB-9E8A-5A1B8DF0E15E @default.
- Q99400845 P2093 Q99400845-8A109345-E2A9-438B-9C49-62C84BBD1C4F @default.
- Q99400845 P2093 Q99400845-8FEA9C73-3D90-4861-A53C-739AF48B4B99 @default.
- Q99400845 P2093 Q99400845-90DD9E6B-FC41-4E7E-86BC-8254E529E7B8 @default.
- Q99400845 P2093 Q99400845-A294D74A-28AC-48F5-9C63-84EF7BC1996D @default.
- Q99400845 P2093 Q99400845-A3985F0E-72A6-4387-960E-E17C53A7C16F @default.
- Q99400845 P2093 Q99400845-B4812342-7357-4F3B-BD0A-ED652AB45263 @default.
- Q99400845 P2093 Q99400845-F55B9CA8-D26A-4C81-87BE-58DB701A5457 @default.
- Q99400845 P304 Q99400845-02613821-CF45-4785-B925-FB679B59EB0B @default.
- Q99400845 P31 Q99400845-C78ED71A-8F10-482B-BEC2-9615576E155F @default.
- Q99400845 P356 Q99400845-1E2F836B-12EB-4F5F-A6BB-A84B94F7888A @default.
- Q99400845 P433 Q99400845-26A8D397-BCC9-4D58-AA00-8447F0419952 @default.
- Q99400845 P478 Q99400845-57C7FD96-4558-4451-BEA2-C22E03996638 @default.
- Q99400845 P577 Q99400845-689CA1A6-B871-4F43-8167-5B3BA2F27FF1 @default.
- Q99400845 P698 Q99400845-F3A93F9C-CAC7-44CA-B97E-28185151A977 @default.
- Q99400845 P921 Q99400845-90EA60C2-1731-48E6-B09D-FDFF5F9C8694 @default.
- Q99400845 P356 JPAD.2020.37 @default.
- Q99400845 P698 32920630 @default.
- Q99400845 P1433 Q27725854 @default.
- Q99400845 P1476 "A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group" @default.
- Q99400845 P2093 "A Anderson" @default.
- Q99400845 P2093 "C O'Gorman" @default.
- Q99400845 P2093 "F DiCesare" @default.
- Q99400845 P2093 "G Grossberg" @default.
- Q99400845 P2093 "H Moebius" @default.
- Q99400845 P2093 "L Ereshefsky" @default.
- Q99400845 P2093 "M Carter" @default.
- Q99400845 P2093 "N Hefting" @default.
- Q99400845 P2093 "P Rosenberg" @default.
- Q99400845 P2093 "R Khoury" @default.
- Q99400845 P2093 "S Dubé" @default.
- Q99400845 P2093 "S Khan" @default.
- Q99400845 P2093 "S Lind" @default.
- Q99400845 P2093 "T Shiovitz" @default.
- Q99400845 P304 "274-282" @default.
- Q99400845 P31 Q13442814 @default.
- Q99400845 P356 "10.14283/JPAD.2020.37" @default.
- Q99400845 P433 "4" @default.
- Q99400845 P478 "7" @default.
- Q99400845 P577 "2020-01-01T00:00:00Z" @default.
- Q99400845 P698 "32920630" @default.
- Q99400845 P921 Q11081 @default.